2. Act No. of 15 of 2010 Act No. 15 of 2010 Cap. 1 In this Act, unless the context otherwise requires— “Agency” means the Patents and Companies Registration Agency established under the Patents and Companies Registration Act, 2010; “anticipation” means the prior invention or disclosure of a claimed invention by another person or the inventor’s own disclosure of the claimed invention by publication, sale or offer to sell if that prior invention or disclosure predates the date of the patent application filing; “applicant” means a person who applies for a grant of a patent or utility model certificate, and includes a person making, any other formal application in accordance with this Act; “ARIPO” means the African Regional Intellectual Property Organisation, established by an agreement adopted at Lusaka on 9 December, 1976; “article” includes any substance, material, equipment, machinery or apparatus, whether affixed to land or not; “assessor” means an expert in Intellectual Property or a relevant field appointed by the Registrar; “assignee” means a person who derives title to an invention from a patentee; “authorised person” includes a contractor, subcontractor, firm or corporation that is authorised, in writing, to undertake an activity for non-commercial purposes for or on behalf of the Government; “Board” means the Board of the Agency constituted in accordance with the Patents and Companies Registration Agency Act, 2010; “Budapest Treaty” means the Treaty on the International Recognition of the Deposit of Micro-organisms for the purposes of Patent Procedure established at Budapest on 28 April, 1977, as amended and modified from time to time; “child” has the meaning assigned to it in the Constitution; “commercially exploit” means to use or develop something for business purposes, and includes selling; “compulsory licence” means a licence granted by the Minister, in accordance with, and for the purposes stated in, section ninety-nine; “convention application” means an application for the grant of a patent from a convention country; Patents [No. 40 of 2016 801 “convention country” means a country or an inter- governmental body which is Party to the Paris Convention; “Convention on Bio-Diversity” means the Convention recognising biological diversity, signed in Rio de Janeiro, in 1992, at the Earth Summit; “date of lodging” means the date on which a document is lodged or where it is deemed by virtue of any provision in this Act to have been lodged; “depository institute’ means a scientific institution established in accordance with the Budapest Treaty; “designated office” means the national office of, or acting for the state designated by the applicant in accordance with the Patent Cooperation Treaty; “DNA” means deoxyribonucleic acid that carries the genetic information in cells and some viruses; “elected office” means the national office of, or acting for, the state elected by the applicant inaccordance with the Patent Cooperation Treaty; “examiner” means an officer appointed in accordance with section eight; “exclusive licence” means a licence, in writing, signed by or on behalf of a patentee authorising the licensee, to the exclusion of all other persons, to exercise a right that would otherwise be exercisable exclusively by the patentee, and “exclusive licensee” shall be construed accordingly, with the necessary modifications; “exploit” means making, importing, offering for sale, selling or using a product or process, and includes stocking up a product for the purpose of offering for sale, selling or using; “filing date” means the date of receipt of an application for the grant of a patent which complies with the requirements stipulated in section twenty-seven; “foreign application” means an application for the grant of a patent or any other protection filed with any other country other than Zambia by an applicant for the grant of a patent in accordance with this Act; “genetic resource” means any genetic material of a biological resource containing genetic information having actual or potential value for humanity and includes derivatives, fauna and flora of terrestrial, aquatic and any other origin which 802 No. 40 of 2016] Patents may be used by the inventor to obtain specific practical outputs in any field of human activity or derivative; “Harare Protocol” means the Protocol for the Protection of Patents, Utility Models and Industrial Designs administered by ARIPO; “industrial application” means an application capable of being made or used in an industry; “international application” means an application for a grant of a patent, filed in accordance with section sixty-two, which designates Zambia for the national grant of a patent in accordance with the Patent Cooperation Treaty and Regulations, including any other international treaty to which Zambia is a State Party; “International Bureau” means the International Bureau of the World Intellectual Property Organisation; “international preliminary examination” means a preliminary and non-binding examination carried out by the International Examination Authority, appointed in accordance with the Patent Cooperation Treaty; “International Searching Authority” means a patent office appointed by the International Bureau in accordance with Articles 16(3) and 32(3) of the Patent Cooperation Treaty; “invention” means a solution to a specific problem in a particular field of technology and includes a product or a process; “inventive step” means a feature of an invention that involves a technical advancement to existing knowledge which makes the invention not obvious to a person skilled in the art; “inventor” means a person who actually devised the invention, and includes the legal representative of an inventor, but does not include a person to whom an invention has been communicated to from within or outside Zambia; “legal representative” means a— (a) liquidator or receiver of a company; (b) person appointed under a power of attorney; (c) person, recognised by law, representing a person who has died, becomes bankrupt or assigns that person’s estate; or (d) person, recognised by law, representing a child, person of unsound mind or person with a legal disability; Patents [No. 40 of 2016 803 S. I No. 73 of 1998 “letters patent” means an instrument that grants the exclusive rights of an invention to an individual or a corporation; “licensee” means a person who has been permitted by a patentee to exploit the patented article, in accordance with the terms and conditions specified in a licence contract; “National Institute for Scientific and Industrial Research” means the National Institute for Scientific and Industrial Research established by the establishment of National Institute for Scientific and Industrial Research Regulations, 1998; “national phase” means the period before the expiry of thirty- one months from the priority date when the applicant submits an application for the grant of a patent as provided for in section sixty-four; “non-commercial purposes” means any activity carried out for non-profit purposes; “novelty” means the newness of an invention both in form and function or performance; “officer” means an employee of the Agency; “Paris Convention” means the Convention for the Protection of Industrial Property signed at Paris on March 20, 1883; “patent” means the letters patent granted for an invention which meets the requirements specified in section fifteen; “patentable” means meeting the requirements specified in of section fifteen (1) and being eligible for protection as a patent as provided in that section, and the word “patentability” shall be construed accordingly; “patented article” means an article in respect of which a patent has been granted, in accordance with section fifteen, and which is in force; “patentee” means a person who is entered in the Register as the holder of a patent, and includes a successor in title; “patent agent” means a person who is registered as a patent agent in accordance with section one hundred and fifteen; “Patent Cooperation Treaty” means the treaty signed at Washington on June 19, 1970; “practitioner” has the meaning assigned to it in the Legal Cap. 30 Practitioners Act; 804 No. 40 of 2016] Patents Act No. 15 of 2010 Cap. 400 “prior art” means knowledge which is publicly known and used by others or is available, on the date of the invention, to a person of ordinary skill in the art, and includes what would be obvious from that knowledge; “priority date” means the cut-off date stipulated in section forty-one; “process” includes a method, art, application or procedure for producing, manufacturing, maintaining or improving the quality of a product; “protected patent” means a patent protected, as specified in section fifteen; “Receiving Office” means a national office or an inter- governmental organisation with which an international application for a grant of a patent has been filed; “Register” means the Register of Patents established and maintained in accordance with section ten; “Registrar” means the person appointed as Registrar under the Patents and Companies Registration Agency Act, 2010; “repealed Act” means the Patents Act, 1958; “specification” means a provisional or complete description of an invention or claim of an invention, as provided in section thirty-one, and includes drawings; “state of the art” means— (a) all matter, whether a product, process or information about anything, which has been made available or disclosed to the public in Zambia in tangible form or by written or oral disclosure or description, by use or in any other way, prior to the lodging or priority date of the application for the grant of a patent; (b) matter contained in an application for another patent which was published or became open to public inspection on or after the priority date of that invention if — (i) that matter was contained in that application for that other patent as lodged, published or opened to public inspection; and (ii) the priority date of that matter is earlier than that of the invention; or Patents [No. 40 of 2016 805 (c) an invention used secretly but on a commercial scale within Zambia; “traditional knowledge” means any knowledge, not limited to a specific subject area, technical or medical field associated with genetic resources, originating from a traditional community, individual or group that is the result of intellectual activity and insight in a traditional context and where the knowledge is embodied in the traditional lifestyle of a traditional community or is codified in knowledge systems and passed on from one generation to another; “utility model” means an intellectual property right with less stringent patentability requirements to protect an invention; “utility model certificate” means a certificate granted for a utility model in accordance with section one-hundred and ten; and “WIPO” means the World Intellectual Property Organisation established on July 14, 1967.